Kristina Davidson’s Post

#DYK over 4.4 million people battle Sickle Cell Disease globally. This disease affects the shape of our red blood cells, leading to severe complications. In today’s world of increasingly complex blood diseases, labs need to be able to do more with a single blood draw.💉🩸 With the Beckman Coulter DxH 900/690T Hematology Analyzer, we provide accurate and reliable results that improve patient outcomes. Ready to unlock the secrets to battling SCD? Access our advanced case study book here 📚 👉 https://bit.ly/3SbiCPe #WorldSickleCellDay #PatientCare #HematologyAnalyzer 

#DYK over 4.4 million people battle Sickle Cell Disease globally. This disease affects the shape of our red blood cells, leading to severe complications. In today’s world of increasingly complex blood diseases, labs need to be able to do more with a single blood draw.💉🩸 With the Beckman Coulter DxH 900/690T Hematology Analyzer, we provide accurate and reliable results that improve patient outcomes. Ready to unlock the secrets to battling SCD? Access our advanced case study book here 📚 👉 https://bit.ly/3SbiCPe #WorldSickleCellDay #PatientCare #HematologyAnalyzer

3 step cure for autoimmune disease? Great vision and overview from Robert Plenge. Step 1 - control inflammation Step 2 - reset the immune system (with CAR-Ts) Step 3 - promote homeostasis & repair https://lnkd.in/ejbNuUtN The article references some really strong data from 2022 where CAR-Ts were used in Systemic Lupus Erythematosus (SLE) to reset the immune system. It was a small study, but 5 of 5 patients were in remission, which persisted for 12 months. https://lnkd.in/eVRXAcHZ In 2024, this was followed up in "severe SLE (8 patients), idiopathic inflammatory myositis (3 patients), [and] systemic sclerosis (4 patients)" which showed similar very strong results. https://lnkd.in/e8kQDGft Very exciting times for the field!

#DYK over 4.4 million people battle Sickle Cell Disease globally. This disease affects the shape of our red blood cells, leading to severe complications. In today’s world of increasingly complex blood diseases, labs need to be able to do more with a single blood draw.💉🩸 With the Beckman Coulter DxH 900/690T Hematology Analyzer, we provide accurate and reliable results that improve patient outcomes. Ready to unlock the secrets to battling SCD? Access our advanced case study book here 📚 👉 https://bit.ly/3SbiCPe #WorldSickleCellDay #PatientCare #HematologyAnalyzer

I will share with you a little poster about the preparation of blood components from whole blood and explain its steps! Also, here are some of the indication -Packed Red cells : Anemia, Thalassemia, Sickle cell disease. - Fresh Frozen Plasma: Liver disease, Massive transfusion, Coagulation factor deficiency, Hemophilia A or B. - Platelets: thrombocytopenia or platelet function disorder

#DYK over 4.4 million people battle Sickle Cell Disease globally. This disease affects the shape of our red blood cells, leading to severe complications. In today’s world of increasingly complex blood diseases, labs need to be able to do more with a single blood draw.💉🩸 With the Beckman Coulter DxH 900/690T Hematology Analyzer, we provide accurate and reliable results that improve patient outcomes. Ready to unlock the secrets to battling SCD? Access our advanced case study book here 📚 👉 https://bit.ly/3SbiCPe #WorldSickleCellDay #PatientCare #HematologyAnalyzer

The management of autoimmune diseases has improved significantly since the beginning of the 21st century. However, treatment is still typically considered to be life-long and aimed at suppressing the symptoms. In this article published in NEJM, Müller et al. present a study of 15 patients with systemic lupus erythematosus (SLE) who were treated with a single infusion of CD19-targeted chimeric antigen receptor (CAR) T cells as B cell depletion is a potential strategy for achieving long-term drug-free remission. Patients received a single CAR T-cell infusion following fludarabine and cyclophosphamide preconditioning. Remarkably, all participants showed significant improvement according to disease-specific remission criteria, and immunosuppressive therapies were entirely discontinued. Although most experienced mild cytokine release syndrome, the therapy demonstrated a promising safety and efficacy profile, suggesting a new avenue for sustained remission in autoimmune diseases. https://lnkd.in/enuSFUpP #immunotherapy #autoimmunedisease #cartcelltherapy

#DYK over 4.4 million people battle Sickle Cell Disease (SCD) globally. This disease affects the shape of our red blood cells, leading to severe complications. In today’s world of increasingly complex blood diseases, labs need to be able to do more with a single blood draw.💉🩸 With the Beckman Coulter DxH 900 Hematology Analyzer, we provide accurate and reliable results that improve patient outcomes. Ready to unlock the secrets to battling SCD? Access our advanced case study book here 📚 👉 https://bit.ly/3SbiCPe #WorldSickleCellDay #PatientCare #HematologyAnalyzer

Inflammation is the body’s normal defence mechanism against injury or infection. It is usually short-lived, however when it lasts too long it can become chronic. Chronic inflammation plays a crucial role in the development of conditions such as obesity, type 2 diabetes, rheumatoid arthritis, asthma, and even cancer. Genetic information obtained from a DNA test provides an insightful tool that can help manage and bring clarity to a patient’s clinical picture. In particular, DNA testing can bring insight into several aspects of inflammation, including uncovering the root cause of inflammation, reducing inflammation, and resolving inflammation. Click below to continue reading this month's new article by guest author arlotta Petti from myDNA which describes various we can use DNA testing in our practice to target inflammation. https://lnkd.in/gg74gB7a 📝 Sign up for our monthly newsletter for the latest exclusive clinical tools, articles, and infographics by clicking the link below: https://lnkd.in/gEjjZisj #fxmedicine #fxmedicinepodcast #article #newarticle #dna #dnatesting #inflammation #chronicinflammation

At Sept 9 2024 #WCLC24 Presidential Symposium Alfredo Addeo, we report encouraging efficacy data for firmonertinib in EGFR PACC mutation NSCLC patients, at 240mg dose level, confirmed ORR of 63.8%, best ORR 82%, disease control rate (DCR) 100%. FURTHER trial is the first prospective clinical trial evaluating a TKI using MDACC structure-functional EGFR classification system. ArriVent Biopharma Zhengbin (Bing) Yao Stuart Lutzker Jerry Hsu Jessie Jiang mdanderson #lungcancer #EGFR